Nova In Silico Employee Directory
Software DevelopmentAuvergne-rhône-alpes, France51-200 Employees
Nova In Silico develops the Jinkō clinical trials simulation platform, used by biotech and pharma companies as well as academic research centers and not-for-profit organizations. The platform supports modeling and simulation to reduce risk and accelerate the development of new therapies, helping identify optimal responders, optimize treatment regimens, generate synthetic control arms, and explore outcomes beyond what conventional trials can reveal. It allows predicting trial results ahead of real-world studies to inform the design of studies with a higher likelihood of success. Based in Lyon in the Auvergne-Rhône-Alpes region of France, the company operates with a mid-sized team. In November 2025, Nova In Silico participated in the AHA Scientific Sessions, publicly sharing time-stamped predictions on Zenodo that were produced independently of Merck and without access to embargoed data.